Japanese Infrastructure Stock News

Shionogi & Co., Ltd. has begun sales in Japan of EndeavorRide, the first approved digital therapeutic support app for pediatric ADHD, following favorable Phase 3 trial results in 164 patients aged 6–17. By introducing a regulated, app-based treatment that targets prefrontal cortex activity via Akili’s SSME (TM) technology, Shionogi is extending ADHD care beyond traditional psychosocial and drug therapies. We will now explore how the launch of this first-in-Japan pediatric ADHD digital...

With inflation trends, energy prices and central bank decisions all pulling markets in different directions, many investors are looking for stocks where earnings are expected to grow and balance sheets still look reasonable. That is exactly what the Healthy high growth potential screener aims to capture, focusing on companies where analysts expect earnings growth over the next 3 years and that meet basic financial strength checks. In this article, you will see 3 of the stocks from this...

Furukawa Electric (TSE:5801) issued fresh consolidated guidance for the fiscal year ending March 31, 2027, outlining targets of ¥1,460,000 million in net sales, ¥95,000 million in operating profit, and ¥82,000 million in profit attributable to shareholders. See our latest analysis for Furukawa Electric. Furukawa Electric's latest guidance arrives after a sharp move in the share price, with a 1-day share price return of 2.84% and a 7-day share price return of 15.59%, offset by a 30-day share...

CREAL Inc. ( TSE:2998 ), is not the largest company out there, but it saw a decent share price growth of 18% on the TSE...

The market rallied behind BEAUTY GARAGE Inc.'s ( TSE:3180 ) stock, leading do a rise in the share price after its...

Nidec Corporation has already held a Board meeting to propose amendments to its Articles of Incorporation and is set to shift key convening and chairing roles for shareholder and board meetings from the Founder and Executive Chairman to the board President, with the changes scheduled to take effect following the June 18, 2026 shareholder vote. Alongside this governance reshuffle, Nidec is also weighing a deadline extension for its latest Annual Securities Report as it investigates improper...

Amidst a backdrop of geopolitical tensions and economic fluctuations, Asian markets have shown resilience with mixed performances across major indices. As investors navigate these complexities, identifying undervalued stocks becomes crucial as they may offer potential opportunities for growth in a volatile environment.

With inflation, interest rates and energy prices all pulling markets in different directions, many investors are looking beyond short term headlines and focusing on who is actually running the companies they own. Founder led stocks bring leaders whose personal legacy is on the line, which can mean closer cost discipline, sharper capital allocation and clearer long term direction. This article looks at our Founder Led Companies screener and highlights three of the stocks identified by it,...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Investors were disappointed with Pharma Foods International Co., Ltd.'s ( TSE:2929 ) earnings, despite the strong...

In June 2026, Oasis Management intensified its campaign against KADOKAWA CORPORATION’s leadership, urging shareholders to vote against CEO Takeshi Natsuno’s reappointment and supporting his dismissal amid governance, compliance, and performance concerns, while the Japan Fair Trade Commission reportedly prepared another recommendation related to freelance treatment. The effort gained momentum when both ISS and Glass Lewis, the leading proxy advisory firms, later advised investors to oppose...

Mitsubishi UFJ Financial Group (TSE:8306) is in focus after forming a joint council with Mizuho Bank and Sumitomo Mitsui Banking Corporation to develop a yen-backed stablecoin, targeting blockchain-based payments under Japan’s regulated stablecoin framework. See our latest analysis for Mitsubishi UFJ Financial Group. Alongside the stablecoin council and the decision to redeem its US$2.1b senior notes in 2026, Mitsubishi UFJ Financial Group shares have produced a 9.25% 1 month share price...

Event overview and why Seiko Group stock is in focus Seiko Group (TSE:8050) has drawn fresh attention after stating that it is considering a reduction in its investment unit. The company described this potential change as a way to broaden its investor base and improve share liquidity. See our latest analysis for Seiko Group. Investors appear to be responding to the potential investment unit reduction, with Seiko Group’s share price at ¥7,780 after a 7.31% 1 day share price return and a year...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Shareholders of PARK24 Co., Ltd. ( TSE:4666 ) will be pleased this week, given that the stock price is up 14% to...

Capcom (TSE:9697) stock is back in focus after a cluster of product announcements, including new expansions for Dragon’s Dogma 2 and Monster Hunter Wilds, a Resident Evil remake and a revived Onimusha installment. See our latest analysis for Capcom. The recent suite of franchise updates appears to have caught investors’ attention, with a 1-day share price return of 4.82% and a 7-day share price return of 3.17%. The share price is still down over the year to date, however, and the 1-year total...

Credit Saison (TSE:8253) has moved into focus after issuing fresh earnings guidance for the fiscal year ending March 2027 and outlining higher dividend plans, giving investors new data on expected cash flows and payouts. See our latest analysis for Credit Saison. The fresh earnings guidance and higher dividend plan appear to have fed into improving sentiment around Credit Saison, with a 1-day share price return of 3.34% and year to date share price return of 5.35%. At the same time, longer...

Kura Oncology and Kyowa Kirin recently reported encouraging long-term Phase 1/2 KOMET-007 results showing that investigational ziftomenib plus 7+3 chemotherapy produced high remission rates, deep molecular responses and a manageable safety profile in newly diagnosed NPM1-m or KMT2A-r acute myeloid leukemia. A distinctive feature of the data is the high rate of early, deep minimal residual disease negativity alongside low treatment-related mortality, highlighting the regimen’s potential to...

Collaboration news puts Sysmex stock in focus Sysmex (TSE:6869) is back on investors' radar after VolitionRx Limited announced a collaboration to optimize its Nu.Q NETs H3.1 assay on the Sysmex platform, targeting diseases linked to NETosis. See our latest analysis for Sysmex. At a share price of ¥1,424.5, Sysmex has seen modest positive share price momentum in the past month with a 1-month share price return of 3.11% and 90-day share price return of 2.85%, yet the 1-year total shareholder...

Dividend increase and new earnings guidance put Token stock in focus Token (TSE:1766) drew investor attention after proposing a higher cash dividend for the fiscal year ended April 2026, outlining further dividend growth guidance and releasing new consolidated earnings projections. See our latest analysis for Token. The dividend and guidance update arrived as Token's share price climbed 3.46% on the day to ¥12,570, yet remains down 13.90% year to date. The 3 year total shareholder return of...

TDK (TSE:6762) stock is back in focus after TDK Ventures backed Aston Power, a power delivery startup for AI and high performance computing data centers, highlighting TDK’s push into energy and AI infrastructure. See our latest analysis for TDK. Those AI and energy efforts are landing at a time when TDK’s ¥3,830 share price has been moving strongly, with a 30 day share price return of 28.63% and a 1 year total shareholder return of 151.51%. This suggests that momentum has been building over...

J.S.B.Co.Ltd (TSE:3480) has put up a punchy Q2 2026 print, with revenue of ¥29.1b and basic EPS of ¥297.64, set against trailing twelve month EPS growth of 14.1% and a 13.8% annualized earnings growth rate over five years. The company has seen quarterly revenue move from ¥27.0b in Q2 2025 to ¥29.1b in Q2 2026, while basic EPS shifted from ¥267.87 to ¥297.64 over the same period, with trailing twelve month revenue at ¥79.6b and basic EPS at ¥315.17. For investors, the combination of higher...

Kobe Bussan (TSE:3038) has put solid numbers on the table for Q2 2026, with revenue of ¥144.6b and basic EPS of ¥47.75, set against a trailing twelve month picture where earnings grew 46% and net profit margin reached 6% from 4.4% a year earlier. The company has seen quarterly revenue move from ¥139.9b in Q2 2025 to ¥144.6b in Q2 2026, while basic EPS over the same quarters went from ¥16.62 to ¥47.75, and trailing twelve month EPS stands at ¥153.90 on revenue of ¥565.6b. With earnings...

Kura Sushi (TSE:2695) opened Q2 2026 with revenue of ¥62.3 billion and net income of ¥759 million, set against a trailing twelve month EPS of ¥58.47 and net income of ¥3.49 billion that benefited from a sharp year over year earnings swing. The company has seen quarterly revenue move in a relatively tight band around the ¥59.1 billion to ¥64.1 billion range over the past six reporting periods. EPS has ranged from ¥1.82 to ¥18.95 per quarter, feeding into that higher trailing figure and helping...